Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1705
Peer-review started: March 11, 2020
First decision: April 1, 2020
Revised: April 9, 2020
Accepted: April 17, 2020
Article in press: April 17, 2020
Published online: May 6, 2020
Processing time: 50 Days and 0.2 Hours
Core tip: The coronavirus disease 2019 (COVID-19) outbreak has become a public health emergency of international concern. Establishing effective control measures is of urgent importance. We here report a case of severe COVID-19. The patient was treated successfully with early non-invasive ventilation when her arterial oxygen partial pressure/fractional inspired oxygen ratio dropped below 200 mmHg, and a bundle pharmacotherapy which included an antiviral cocktail (lopinavir/ritonavir plus α-interferon), an immunity enhancer (thymosin), a corticosteroid to reduce pulmonary exudation (methylprednisolone), a traditional Chinese medicine-derived anti-inflammatory prescription (Xuebijing), and an anti-coagulant to prevent deep vein thrombosis (heparin). Early non-invasive ventilation with a bundle pharmacotherapy may be an effective regimen for patients with COVID-19.
